NURS 1566 Clinical Form 3: Clinical Medications Worksheets

(You will need to make additional copies of these forms)

Generic Name Trade Name Classification Dose Route Time/frequency

Enoxaparin Lovenox Low molecular 40 mg SQ Daily
weight heparins
Peak Onset Duration Normal dosage range
Unknown Unknown 12 hrs Medical patients with acute illness--40 mg once daily

Why is your patient getting this medication For IV meds, compatibility with IV drips and/or solutions
Prevention of DVT/Pulmonary Embolism N/A

Mechanism of action and indications Nursing Implications (what to focus on)

(Why med ordered)
Potentiates the inhibitory effect of antithrombin on factor Xa
and thrombin. Indicated for prevention and treatment of DVT
and Pulmonary Embolism
Interactions with other patient drugs, OTC or herbal
medicines (ask patient specifically)
Increased risk for bleeding if used with asparin
Nursing Process- Assessment
(Pre-administration assessment)
Assess for signs of bleeding and hemorrhage
(bleeding gums; nosebleed; unusual bruising;
black, tarry stools; hematuria; fall in hematocrit or
blood pressure; guaiac-positive stools); bleeding
from surgical site. Notify physician or other health
care professional if these occur
Contraindications/warnings/interactions
Contraindicated in: Hypersensitivity, active major bleed. Use
cautiously in severe kidney or liver disease, untreated hypertention,
recent history of ulcer disease. Interacts with other blood thinning agents
and drugs and foods with anticoagulant effects.
Common side effects
Bleeding, anemia
Lab value alterations caused by medicine
Monitor CBC, platelet count, and stools for occult blood periodically
during therapy. If thrombocytopenia occurs, monitor closely. If
hematocrit decreases unexpectedly, assess patient for potential bleeding
sites. Special monitoring of clotting times (aPTT) is not necessary in
most patients. Monitoring of the aPTT may be considered in certain
patient populations (such as obese patients or patients with renal
insufficiency)
Be sure to teach the patient the following about this
medication
Advise patient to report any symptoms of unusual bleeding or bruising,
dizziness, itching, rash, fever, swelling, or difficulty breathing to health
care professional immediately
Assessment Evaluation
Why would you hold or not give this Check after giving
med? Signs of bleeding and hemorrhage.
If signs of bleeding and hemorrhage Monitor patient for hypersensitivity
reactions (chills, fever, urticaria).
are present. Report signs to physician or other
health care professional. Observe
injection sites for hematomas,
ecchymosis, or inflammation. For
overdose protamine sulfate, 1mg for
each mg of enoxaparin should be
administered by slow IV injection.